Foundry Partners’s AngioDynamics ANGO Stock Holding History

Foundry Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-301,942	Closed	-$4.83M	–	380
2019 Q4	$4.83M	Buy	301,942 +56,738	+23%	+$867K	0.18%	169
2019 Q3	$4.52M	Sell	245,204 -12,988	-5%	-$254K	0.19%	177
2019 Q2	$5.08M	Sell	258,192 -29,563	-10%	-$602K	0.2%	167
2019 Q1	$6.58M	Sell	287,755 -51,074	-15%	-$1.11M	0.26%	135
2018 Q4	$6.82M	Sell	338,829 -12,704	-4%	-$263K	0.31%	109
2018 Q3	$7.64M	Sell	351,533 -34,312	-9%	-$762K	0.29%	126
2018 Q2	$8.58M	Sell	385,845 -2,225	-0.6%	-$45.5K	0.35%	106
2018 Q1	$6.69M	Buy	388,070 +2,175	+0.6%	+$36.3K	0.28%	131
2017 Q4	$6.42M	Sell	385,895 -13,505	-3%	-$230K	0.27%	140
2017 Q3	$6.83M	Buy	+399,400	New	+$6.71M	0.27%	138

Other funds holding ANGO

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Foundry Partners's ANGO Position: Q1 2020 in Review

Foundry Partners sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 301,942 shares — an estimated $4.83M sold.

Foundry Partners first reported a position in ANGO in Q3 2017 and held it in 10 quarters. The position peaked at $8.58M in Q2 2018. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

Foundry Partners reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
Foundry Partners sold 301,942 AngioDynamics shares in Q1 2020, an estimated $4.83M.
Foundry Partners first reported a position in AngioDynamics in Q3 2017 and held it in 10 quarters.
Foundry Partners's AngioDynamics position peaked at $8.58M in Q2 2018.
158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on Foundry Partners's 13F filing for Q1 2020, filed 8 May 2020.